Agile Therapeutics drops after announcing stock offering

Agile Therapeutics

07/10/2021 21:43

** Drug developer's shares  AGRX.O  slump 21% to 74 cents in
extended trading
    ** Stock is the biggest loser on Nasdaq in after-hours
trading 
    ** Co offers to sell common shares and warrants, does not
disclose size of the offering  urn:newsml:reuters.com:*:nGNX3bfGDP
    ** Oppenheimer & Co is the sole underwriter - AGRX 
    ** Stock has a consensus rating of "strong buy" with a
median PT of $4 - Refinitiv IBES data
    ** YTD, shares have plunged 67%

 (Reporting by Niket Nishant in Bengaluru)
 ((Niket.Nishant@thomsonreuters.com;))